DAL MONTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 12.059
AS - Asia 6.366
EU - Europa 4.996
SA - Sud America 817
AF - Africa 380
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.639
Nazione #
US - Stati Uniti d'America 11.709
SG - Singapore 2.006
CN - Cina 1.893
IT - Italia 1.879
HK - Hong Kong 864
BR - Brasile 692
SE - Svezia 662
VN - Vietnam 414
DE - Germania 397
BG - Bulgaria 382
FI - Finlandia 272
CA - Canada 259
FR - Francia 258
GB - Regno Unito 248
KR - Corea 217
RU - Federazione Russa 214
UA - Ucraina 210
TR - Turchia 191
JP - Giappone 178
IN - India 168
CI - Costa d'Avorio 127
AT - Austria 106
CH - Svizzera 89
ID - Indonesia 69
NL - Olanda 68
BD - Bangladesh 65
NG - Nigeria 63
EG - Egitto 61
IQ - Iraq 48
AR - Argentina 41
MX - Messico 41
BE - Belgio 40
PK - Pakistan 38
PL - Polonia 37
SA - Arabia Saudita 34
KE - Kenya 29
SN - Senegal 27
ZA - Sudafrica 27
ES - Italia 24
PH - Filippine 23
VE - Venezuela 19
CZ - Repubblica Ceca 18
IE - Irlanda 17
MY - Malesia 17
UZ - Uzbekistan 17
EC - Ecuador 16
IL - Israele 16
AL - Albania 15
JO - Giordania 15
AU - Australia 14
CO - Colombia 13
HU - Ungheria 13
MA - Marocco 11
TH - Thailandia 11
AZ - Azerbaigian 10
JM - Giamaica 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
OM - Oman 9
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
LT - Lituania 8
PE - Perù 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
DK - Danimarca 7
DZ - Algeria 7
BO - Bolivia 6
CL - Cile 6
GR - Grecia 6
LB - Libano 6
PT - Portogallo 6
UY - Uruguay 6
AO - Angola 5
HN - Honduras 5
PS - Palestinian Territory 5
TW - Taiwan 5
EU - Europa 4
KG - Kirghizistan 4
PA - Panama 4
BJ - Benin 3
MU - Mauritius 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
BS - Bahamas 2
CR - Costa Rica 2
GE - Georgia 2
GY - Guiana 2
IR - Iran 2
MD - Moldavia 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
AM - Armenia 1
Totale 24.614
Città #
Ashburn 1.362
Singapore 1.178
Fairfield 947
Woodbridge 861
Hong Kong 844
Santa Clara 710
Chandler 705
Dallas 677
San Jose 659
Houston 625
Ann Arbor 515
Shanghai 384
Seattle 382
Sofia 380
Beijing 369
Milan 366
Serra 340
Wilmington 322
Cambridge 317
Hefei 280
New York 280
Seoul 211
Council Bluffs 210
Ottawa 203
Boardman 198
Jacksonville 182
Princeton 178
Los Angeles 175
Lauterbourg 149
Lawrence 146
Tokyo 138
Munich 136
Medford 132
Helsinki 127
Abidjan 126
Des Moines 115
Nanjing 109
Ho Chi Minh City 108
Vienna 87
Izmir 86
Florence 72
Istanbul 72
Redondo Beach 71
London 68
Pisa 65
Hanoi 63
Bern 59
Buffalo 59
Lagos 59
Columbus 58
San Diego 58
Frankfurt am Main 56
São Paulo 56
Dong Ket 54
Chicago 52
Falls Church 49
Dearborn 48
The Dalles 48
Nanchang 45
Rome 45
Boulder 37
Brussels 37
Kunming 34
Redwood City 34
Jüchen 33
Cairo 29
Livorno 29
Jakarta 28
Marseille 28
Dakar 27
Orem 26
Zurich 26
Washington 25
Nuremberg 24
Guangzhou 23
Mumbai 23
Warsaw 23
Changsha 22
Shenyang 22
Baghdad 21
Belo Horizonte 21
Nairobi 20
Ogden 20
Pune 20
Alessandria 19
Baltimore 19
Norwalk 19
Chennai 18
Napoli 18
San Francisco 18
Catania 17
Hebei 17
Jeddah 17
Rio de Janeiro 17
Bari 16
Fuzhou 16
Lappeenranta 16
Brno 15
Brooklyn 15
Hangzhou 15
Totale 17.380
Nome #
Dexamethasone Improves Ofloxacin Efficacy in Treating Acute Bacterial Conjunctivitis: Evidence from A Rabbit Model 548
Exposure to extreme climatic environments reduces circulating endothelial progenitor cells. 370
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 273
Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy 235
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy 230
S-thiolation mechanisms of aldose reductase 215
Agonisti selettivi dei recettori beta-adrenergici di tipo 3 (BAR3) e loro impiego 213
Diabetic retinopathy: Neuroprotection as a therapeutic target 196
Somatostatin (SRIF) and SRIF receptors in the mouse retina 192
Involvement of cysteine residues in glutathione dependent modification of human aldose reductase 190
Zofenoprilat-Glutathione mixed disulfide as a specific S-thiolating agent of bovine lens aldose reductase 189
Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy 189
Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2 188
A new approach against sugar cataract through aldose reductase inhibitors 187
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants 185
Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin 184
VEGF as a survival factor in ex vivo models of early diabetic retinopathy 184
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity 184
Prooxidative action of cysteine in the glutathione-mediated oxidative modification of lens aldose reductase 183
A nature‐inspired nrf2 activator protects retinal explants from oxidative stress and neurodegeneration 183
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy 183
Neurosensory Alterations in Retinopathy of Prematurity: A Window to Neurological Impairments Associated to Preterm Birth 182
In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression 181
Specifically targeted modification of human aldose reductase by physiological disulfides 179
Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors 179
Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors hMT1 and hMT2 178
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases 178
Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System 177
The pathophisiology of retinopathy of prematurity: an update of previous and recent knowledge 176
Lens glutathione S-transferase as a catalyst of transthiolation processes 174
The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes 174
Morpho-functional analysis of the early changes induced in retinal ganglion cells by the onset of diabetic retinopathy: The effects of a neuroprotective strategy 173
Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4 173
The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization 169
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside 169
Purification and characterization of two odorant binding proteins from nasal tissue of rabbit and pig 168
SITE-SPECIFIC OXIDATION OF BOVINE LENS ALDOSE REDUCTASE INDUCED BY COPPER-ION 167
Alpha-crystallin acting as a molecular chaperone in preventing thermal induced denaturation of bovine lens sorbitol dehydrogenase 167
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina 167
β3 adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling. 166
Modulation of aldose reductase activity through S-thiolation by physiological thiols 166
Increased efficacy of dietary supplement containing wax ester-rich marine oil and xanthophylls in a mouse model of dry macular degeneration 165
The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadow 165
Liposome-Mediated Delivery Improves the Efficacy of Lisosan G against Retinopathy in Diabetic Mice 165
Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection 164
Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule. 163
GLUTATHIONE-MODIFIED ALDOSE REDUCTASE IN OXIDATIVELY STRESSED BOVINE LENS 162
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy. 162
Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy 161
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function 161
Efficacy of fatty acids dietary supplement in polyethylene glycol-induced mouse model of retinal degeneration 160
Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives 160
Acetyl-11-keto--boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy 158
Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa 157
Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis 156
Thiol/disulfide interconversion in bovine lens aldose reductase induced by intermediates of glutathione turnover 155
β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells 154
Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina 152
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. 152
The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance Between Apoptosis and Autophagy 152
The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model 152
Vascular Endothelial Growth Factor in the Ischemic Retina and Its Regulation by Somatostatin 151
Anti-angiogenic effectiveness of the urokinase receptor-derived peptide UPARANT in a model of oxygen induced retinopathy 151
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 150
Reversibility of S-thiolation of aldose reductase in intact bovine lens undergoing oxidative stress 149
Functional correlates of somatostatin receptor 2 over-expression in the retina of mice with genetic deletion of somatostatin receptor 1 149
Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia 148
Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage 147
Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. 147
Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy 147
Mechanisms underlying somatostatin receptor 2 downregulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants 146
Autophagy Involvement in the Postnatal Development of the Rat Retina 146
HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina 146
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia 144
Chaperone-like activity of alpha-crystallin against thermal denaturation of sorbitol dehydrogenase 144
Therapeutic Potential of Anti-Angiogenic Multi-Target N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy. 144
Somatostatin coupling to adenylyl cyclase activity in the mouse retina 144
Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo 144
Solid phase enzyme immunoassay for the Odorant Binding Protein (OBP) 143
Inactivation of bovine lens aldose reductase by 4-hydroxynonenal 142
Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice 142
Expression of Substance P, Neurokinin 1 receptors (NK1)and Neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knock out mice 141
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization 141
The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress 141
Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices 140
Localization patterns of fibroblast growth factor 1 and its receptors FGFR1 and FGFR2 in postnatal mouse retina 140
Interconversion pathways of aldose reductase induced by thiol compounds 139
Indirect blockade of vascular endothelial growth factor: the potential for eye disease therapy 139
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial 139
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy 139
Inhibiting The uPA/uPAR Pathway Affords Photoreceptor Resilience and Preserves Retinal Function in a Mouse Model of Retinitis Pigmentosa 138
Propranolol concentrations after oral administration in term and preterm neonates 138
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP) 138
Effects of Somatostatin Analogues on Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy: Involvement of the Somatostatin Receptor Subtype 2 137
Cysteinylglycine hydrolase activity in bovine lens 135
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission 135
S-Thiolation of enzymes as a defence mechanism against oxidative stress 134
Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis. 134
Diabetes exacerbates the intraocular pressure-independent retinal ganglion cells degeneration in the DBA/2J model of glaucoma 133
UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis 132
Totale 16.877
Categoria #
all - tutte 70.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021313 0 0 0 0 0 0 0 0 0 0 112 201
2021/20221.904 75 142 65 93 295 299 72 95 113 59 113 483
2022/20232.278 249 280 131 187 263 307 25 156 519 16 123 22
2023/20241.776 179 171 216 125 293 324 58 63 37 72 51 187
2024/20255.648 61 214 78 282 570 620 532 273 556 709 627 1.126
2025/20266.226 447 942 725 371 569 579 1.043 324 512 701 13 0
Totale 25.166